Amylyx Pharmaceuticals
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
20.23 | 57.09 | -64.57% | 6.2 | +226.52% |
| P/S |
|
2.95 | 33.5 | -91.2% |
|
|
| P/BV |
|
1.56 | 4.61 | -66.12% |
|
|
| P/FCF |
|
-8.1 | 39.66 | -120.44% |
|
|
| Ev/Ebitda |
|
-0.6261 | -19.46 | -96.78% |
|
|
| Ev/S |
|
2.08 | 22.56 | -90.76% |
|
|
| Ev/FCF |
|
-1.09 | 45.47 | -102.39% |
|
|
| E/P |
|
-0.2219 | 0.0172 | -1386.57% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-333.03 | -14.42 | 2209.43% | -313.81 | +6.13% |
| ROE |
|
-100.88 | 9.01 | -1219.64% |
|
|
| ROA |
|
-84.87 | 0.0151 | -560479.35% |
|
|
| ROIC |
|
-48.93 | 7.63 | -740.92% |
|
|
| ROS |
|
-345.36 | -26.5 | 1203.01% |
|
|
| ROCE |
|
-177.15 | 13.75 | -1388.09% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0068 | -3.73 | -99.82% | 0.0049 | -238.67% |
| Nеt Debt/Ebitda |
|
0.2592 | -3.19 | -108.12% |
|
|
| Debt/Ratio |
|
0.0102 | 0.1777 | -94.24% |
|
|
| Debt/Equity |
|
0.7619 | 1.57 | -51.52% |
|
|
| Debt/Net Income |
|
-0.0066 | 0.8429 | -100.78% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
1 | 0.7368 | 35.71% | ||
| DSI |
|
0.7 | 0.2387 | 193.23% |
|
|
| Average dividend growth |
|
6.92 | 1.55 | 347.65% |
|
|
| Average percentage for 5 years |
|
0 | 0.4967 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.73 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
13341.69 | 73.67 | 18010.07% | ||
| Growth impulse Ebitda in 5 years |
|
627.6 | 15.28 | 4007.33% | ||
| Growth impulse Net Income in 5 years |
|
618.44 | -33.08 | -1969.53% | ||
| Growth impulse FCF in 5 years |
|
353.52 | -6.99 | -5157.51% | ||
| Growth impulse EPS in 5 years |
|
376.14 | -59.11 | -736.34% |
IP Score
5.74/10
